Valuation Shandong Pharmaceutical Glass Co.Ltd
Stocks
600529
CNE000001BG9
Non-Paper Containers & Packaging
|
End-of-day quote
Shanghai S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 18.07 CNY | -0.71% |
|
-1.15% | -9.33% |
| 09-18 | Shandong Pharmaceutical Glass Seeks Up to 3.2 Billion Yuan from Private Placement | MT |
| 08-24 | Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Shandong Pharmaceutical Glass Co.Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,119 | 18,847 | 16,989 | 17,101 | 13,226 | 11,992 | - | - |
| Change | - | -27.84% | -9.86% | 0.66% | -22.66% | -9.33% | - | - |
| Enterprise Value (EV) 1 | 25,234 | 17,500 | 15,524 | 16,036 | 12,166 | 9,045 | 8,596 | 8,117 |
| Change | - | -30.65% | -11.29% | 3.3% | -24.13% | -25.65% | -4.97% | -5.57% |
| P/E | 44.3x | 27.6x | 21.9x | 18.1x | 19.2x | 16.1x | 14.6x | 13.5x |
| PBR | 5.59x | 2.71x | 2.25x | 2.14x | 1.59x | 1.38x | 1.29x | 1.21x |
| PEG | - | 6.83x | 1.6x | 0.8x | -0.7x | 2.09x | 1.4x | 1.76x |
| Capitalization / Revenue | 6.74x | 4.5x | 3.41x | 3.34x | 2.96x | 2.49x | 2.38x | 2.26x |
| EV / Revenue | 6.51x | 4.18x | 3.12x | 3.13x | 2.72x | 1.88x | 1.7x | 1.53x |
| EV / EBITDA | 26.9x | 17.4x | 12.5x | 10.7x | 9.22x | 6.41x | 5.8x | 5.3x |
| EV / EBIT | 36.1x | 24.6x | 16.9x | 14.4x | 14.5x | 8.32x | 8.18x | 7.23x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.3 | 0.3 | 0.4 | 0.32 | 0.18 | 0.48 | 0.52 | 0.56 |
| Rate of return | 0.68% | 1.06% | 1.56% | 1.24% | 0.9% | 2.66% | 2.88% | 3.1% |
| EPS 2 | 0.99 | 1.03 | 1.17 | 1.42 | 1.04 | 1.12 | 1.24 | 1.335 |
| Distribution rate | 30.3% | 29.1% | 34.2% | 22.5% | 17.3% | 42.9% | 41.9% | 41.9% |
| Net sales 1 | 3,875 | 4,187 | 4,982 | 5,125 | 4,474 | 4,822 | 5,042 | 5,315 |
| EBITDA 1 | 938.9 | 1,006 | 1,241 | 1,498 | 1,319 | 1,412 | 1,481 | 1,533 |
| EBIT 1 | 698.3 | 711.1 | 916.4 | 1,113 | 838 | 1,087 | 1,051 | 1,122 |
| Net income 1 | 591.1 | 618.3 | 775.8 | 943 | 689.6 | 740 | 825.2 | 886.7 |
| Net Debt 1 | -885 | -1,347 | -1,465 | -1,065 | -1,060 | -2,946 | -3,396 | -3,874 |
| Reference price 2 | 43.90 | 28.40 | 25.60 | 25.77 | 19.93 | 18.07 | 18.07 | 18.07 |
| Nbr of stocks (in thousands) | 594,968 | 663,614 | 663,614 | 663,614 | 663,614 | 663,614 | - | - |
| Announcement Date | 4/25/22 | 4/24/23 | 4/22/24 | 4/24/25 | 3/6/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.25x | 1.81x | 6.47x | 2.53% | 1.79B | |
| 14.33x | 1.37x | 8.4x | 5.98% | 20.26B | |
| 18.54x | 2.95x | 8.3x | 3.32% | 18.63B | |
| 17.92x | 1.5x | 10.33x | 1.27% | 16.73B | |
| 18.48x | 1.79x | 10.95x | 2.26% | 13.29B | |
| 15.3x | 1.27x | 8.25x | 1.23% | 12.27B | |
| 18.78x | 2.24x | 10.61x | 1.49% | 11.73B | |
| 30.17x | 1.1x | 8.19x | 2.81% | 8.96B | |
| 23.35x | 2.18x | 10.55x | 1.56% | 7.92B | |
| Average | 19.23x | 1.80x | 9.12x | 2.49% | 12.4B | |
| Weighted average by Cap. | 18.58x | 1.83x | 9.30x | 2.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600529 Stock
- Valuation Shandong Pharmaceutical Glass Co.Ltd
Select your edition
All financial news and data tailored to specific country editions
